Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death
- PMID: 21037084
- PMCID: PMC2993293
- DOI: 10.2353/ajpath.2010.100442
Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death
Abstract
Glatiramer acetate (GA) is a synthetic, random, basic copolymer capable of modulating adaptive T cell responses. In animal models of various inflammatory and degenerative central nervous system disorders, GA-induced T cells cross the blood-brain barrier, secrete high levels of anti-inflammatory cytokines and neurotrophins, and thus both reduce neuronal damage and promote neurogenesis. Recently, it has been suggested that GA itself may permeate the (impaired) blood-brain-barrier and directly protect neurons under conditions of inflammation-mediated neurodegeneration. To test this hypothesis, we examined the direct effects of GA on neuronal functionality and T cell-mediated neuronal apoptosis in culture, acute brain slices, and focal experimental autoimmune encephalomyelitis. GA caused a depolarization of the resting membrane potential and led to an immediate impairment of action potential generation in neurons. Moreover, GA-incubated neurons underwent dose-dependent apoptosis. Apoptosis of ovalbumin peptide-loaded major histocompatibility complex class I-expressing neurons induced by ovalbumin-specific effector T cells could be reduced by pre-incubation of T cells, but not neurons with GA. Similar results could be found using acute brain slices. In focal experimental autoimmune encephalomyelitis, lesion size and neuronal apoptosis could be limited by pretreating rats with GA, whereas intracerebral GA application into the inflammatory lesion had no effect on neuronal survival. Our data suggest that GA attenuates adaptive pro-inflammatory T cell responses, but does not exert direct neuroprotective effects.
Figures




Similar articles
-
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19045-50. doi: 10.1073/pnas.0509438102. Epub 2005 Dec 19. Proc Natl Acad Sci U S A. 2005. PMID: 16365293 Free PMC article.
-
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.Exp Neurol. 2010 Jan;221(1):136-45. doi: 10.1016/j.expneurol.2009.10.015. Epub 2009 Oct 29. Exp Neurol. 2010. PMID: 19879259
-
Glatiramer acetate treatment directly targets CD11b(+)Ly6G(-) monocytes and enhances the suppression of autoreactive T cells in experimental autoimmune encephalomyelitis.Scand J Immunol. 2011 Sep;74(3):235-243. doi: 10.1111/j.1365-3083.2011.02575.x. Scand J Immunol. 2011. PMID: 21595733
-
The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.Autoimmun Rev. 2013 Mar;12(5):543-53. doi: 10.1016/j.autrev.2012.09.005. Epub 2012 Oct 7. Autoimmun Rev. 2013. PMID: 23051633 Review.
-
Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.J Autoimmun. 2014 Nov;54:81-92. doi: 10.1016/j.jaut.2014.05.005. Epub 2014 Jun 14. J Autoimmun. 2014. PMID: 24934599 Review.
Cited by
-
Platelets induce apoptosis via membrane-bound FasL.Blood. 2015 Sep 17;126(12):1483-93. doi: 10.1182/blood-2013-12-544445. Epub 2015 Jul 31. Blood. 2015. PMID: 26232171 Free PMC article.
-
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.J Neuroimmune Pharmacol. 2013 Jun;8(3):651-63. doi: 10.1007/s11481-013-9436-x. Epub 2013 Jan 31. J Neuroimmune Pharmacol. 2013. PMID: 23370991
-
Neuronal Mitochondrial Calcium Uniporter (MCU) Deficiency Is Neuroprotective in Hyperexcitability by Modulation of Metabolic Pathways and ROS Balance.Mol Neurobiol. 2024 Nov;61(11):9529-9538. doi: 10.1007/s12035-024-04148-x. Epub 2024 Apr 23. Mol Neurobiol. 2024. PMID: 38652352 Free PMC article.
-
Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE.Int J Biol Sci. 2011;7(8):1188-202. doi: 10.7150/ijbs.7.1188. Epub 2011 Oct 27. Int J Biol Sci. 2011. PMID: 22043176 Free PMC article.
-
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.J Neuroinflammation. 2015 Aug 12;12:146. doi: 10.1186/s12974-015-0365-x. J Neuroinflammation. 2015. PMID: 26259673 Free PMC article.
References
-
- Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar C, Kwon OJ, Brenner T, Arnon R, Sela M. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells–specificity and promiscuity. Proc Natl Acad Sci USA. 1994;91:4872–4876. - PMC - PubMed
-
- Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, Wekerle H, Hohlfeld R. Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci USA. 2000;97:7452–7457. - PMC - PubMed
-
- Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, Lee L, Patarroyo JC, Stuve O, Sobel RA, Steinman L, Zamvil SS. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med. 2007;13:935–943. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases